Host Alicia Sutton welcomes Dr. Arif Kamal, Director of Quality and Outcomes at the Duke Cancer Institute, to talk about ways in which clinicians can become more involved or even take the reins of leadership in quality improvement initiatives within their health systems. The discussion pays close attention to the burgeoning field of Big Data, and how its rapid entry into healthcare impacts quality improvement efforts.
Big Data in Quality Improvement: The Clinician's Role
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Related
videoBig Data in Medicine: "The Good, the Bad, and the Creepy" Implications for Patient Care
Show more- audio
The Looming Shortage of Primary Care Physicians
Show more - video
The Gravity of Success: Thriving in a Changing Business Environment
Show more - audio
What is Quality Improvement Really About? Answers from Duke's Clinical Research Institute
Show more
Recommended
Details
Presenters
Related
In Collaboration with
Overview
Host Alicia Sutton welcomes Dr. Arif Kamal, Director of Quality and Outcomes at the Duke Cancer Institute, to talk about ways in which clinicians can become more involved or even take the reins of leadership in quality improvement initiatives within their health systems. The discussion pays close attention to the burgeoning field of Big Data, and how its rapid entry into healthcare impacts quality improvement efforts.
- video
Big Data in Medicine: "The Good, the Bad, and the Creepy" Implications for Patient Care
Show more - audio
The Looming Shortage of Primary Care Physicians
Show more - video
The Gravity of Success: Thriving in a Changing Business Environment
Show more - audio
What is Quality Improvement Really About? Answers from Duke's Clinical Research Institute
Show more
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Evolving Our View of the Coagulation Cascade and Stroke Management
0.25 credits
<p><span data-contrast="auto" xml:lang="EN-US">Evolving Our View of the Coagulation Cascade and Stroke Management</span><span data-ccp-props='{"201341983":0,"335559739":0,"335559740":240}'> </span></p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
MinuteCE®
M3: Managing the Cardiometabolic Risk in MASH
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">M3: Managing the Cardiometabolic Risk in MASH</span><span data-ccp-props='{"201341983":0,"335559739":160,"335559740":259}'> </span></p>
MinuteCE®
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
1.00 credits
<p><span data-contrast="none" xml:lang="EN-US">Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli</span> </p>
CME/CE
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
0.50 credits
<p>Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 credits
<p>Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?